Picard Medical Investors Face April 13 Lead-Plaintiff Deadline in Securities Class Action

Overview

• No class has been certified, and notices from Rosen Law Firm and Faruqi & Faruqi advise eligible investors to move by April 13, 2026 to seek the lead-plaintiff role.
• The putative class covers purchasers of Picard Medical securities from September 2 through October 31, 2025.
• The complaint alleges a social-media promotion campaign that used impersonated financial professionals and coordinated share dumping via offshore or nominee accounts.
• Plaintiffs contend company statements and risk disclosures omitted false-rumor and artificial-trading activity, rendering upbeat commentary misleading.
• A notice cites a one-day share drop of about 59.8% on October 24, 2025, from $13.20 to $5.31, during the period at issue.